活檢設備:技術和全球市場
市場調查報告書
商品編碼
1262661

活檢設備:技術和全球市場

Biopsy Devices: Technologies and Global Markets

出版日期: | 出版商: BCC Research | 英文 136 Pages | 訂單完成後即時交付

價格

全球活檢設備市場規模預計將從 2022 年的 22 億美元增長到 2027 年的 31 億美元,預測期內的複合年增長率為 6.8%。

北美預計將從 2022 年的 9.769 億美元增長到 2027 年的 14 億美元,在預測期內以 7.1% 的複合年增長率增長。 亞太地區預計也將從 2022 年的 4.876 億美元增長到 2027 年的 7.119 億美元,預測期內復合年增長率為 7.9%。

在本報告中,我們研究了全球活檢設備市場,提供了市場概況、影響市場增長的各種因素的分析、市場規模的趨勢和預測、按細分市場和地區、技術和專利的詳細分析。趨勢、競爭格局, 主要公司概況等

內容

第一章介紹

第 2 章要點摘要

第 3 章活檢設備概述

  • 活檢
  • 活檢類型
    • 骨髓抽吸和活檢
    • 核心活檢
    • 子宮內膜活檢
    • 內窺鏡活檢
    • 切除和切口活檢
    • 細針穿刺 (FNA) 活檢
    • 前哨淋巴結活檢
    • 皮膚活檢
    • 切片活檢
    • 穿刺活檢
  • 活檢裝置
  • 活檢設備的監管
  • 市場動態
    • 市場驅動力
    • 市場製約因素
    • 市場機會
    • 癌症診斷和影像學

第 4 章活檢設備市場,按產品類型分類

  • 活檢引導系統
  • 針式活檢槍
    • 穿刺活檢 (CNB)
    • 細針穿刺活檢 (FNAB)
    • 真空輔助活檢 (VAB)
  • 活檢針
  • 活檢鉗
  • 其他
    • 活檢刷
    • 活檢刮匙
    • 活檢穿孔器

第 5 章活檢設備市場:按圖像引導技術

  • 用於活檢引導的成像技術
    • MRI 引導的活檢
    • 立體定向引導活檢
    • 立體定向穿刺活檢的優勢
    • 立體定向穿刺活檢的缺點
    • 超聲引導活檢
    • 肝活檢
    • 甲狀腺活檢
    • 前列腺活檢
    • 乳房活檢
    • 趨勢
    • CT
    • CT 引導穿刺活檢的優勢
    • CT 引導穿刺活檢的缺點
    • CT 引導穿刺活檢的局限性
    • 其他

第 6 章活檢設備市場,按應用

  • 乳房活檢
  • 胃腸道活檢
  • 前列腺活檢
    • 圖像引導前列腺活檢
    • 前列腺活檢的風險
  • 肝活檢
    • 肝活檢趨勢
    • 肝病數據
    • 經皮肝活檢
    • 腹腔鏡手術
  • 肺活檢
    • 肺活檢的好處
    • 肺活檢的缺點
  • 腎活檢
    • 用於腎臟疾病檢測的活檢並發症
    • 腎臟/腎臟活檢的好處
    • 腎臟/腎臟活檢的缺點
  • 婦科活檢
    • 婦科活檢的並發症
  • 用於診斷其他疾病的活檢設備
    • 胰腺癌活檢
    • 胰腺癌活檢

第 7 章活檢設備市場:按最終用戶分類

  • 診斷實驗室
  • 醫院

第 8 章活檢設備市場:按地區

  • 市場概況和注意事項
  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第 9 章 COVID-19 的影響

第 10 章活檢設備市場的新興技術

  • 劍橋前列腺活檢設備 (CamPROBE)
  • 顯微活檢技術
  • 虛擬活檢設備
  • 光學活檢

第11章專利審查

第12章競爭格局

  • 全球公司排名

第13章公司簡介

  • ARGON MEDICAL DEVICES INC.
  • B. BRAUN MELSUNGEN AG
  • BECTON, DICKINSON AND CO. (CAREFUSION CORP.)
  • BOSTON SCIENTIFIC CORP.
  • CARDINAL HEALTH INC.
  • CONMED CORP.
  • COOK MEDICAL INC.
  • DTR MEDICAL LTD.
  • DANAHER CORP. (MAMMOTOME)
  • FUJIFILM HOLDINGS CORP.
  • HOLOGIC INC.
  • INRAD INC.
  • MERIT MEDICAL SYSTEMS INC.
  • MDNA LIFE SCIENCES INC.
  • MAUNA KEA TECHNOLOGIES
  • MEDTRONIC
  • MDXHEALTH INC.
  • OLYMPUS CORP.

第 14 章附錄 A:公司聯繫方式

第 15 章附錄 B:縮寫

Product Code: HLC171C

Highlights:

The global biopsy devices market should reach $3.1 billion by 2027 from $2.2 billion in 2022 at a compound annual growth rate (CAGR) of 6.8% for the forecast period of 2022 to 2027.

North American biopsy devices market is expected to grow from $976.9 million in 2022 to $1.4 billion in 2027 at a CAGR of 7.1% for the forecast period of 2022 to 2027.

Asia-Pacific biopsy devices market is expected to grow from $487.6 million in 2022 to $711.9 million in 2027 at a CAGR of 7.9% for the forecast period of 2022 to 2027.

Report Scope:

This research report presents an in-depth analysis of the global market for biopsy devices, segmented by product type, imaging technique, application, end user and geographic markets. It discusses key devices (vacuum-assisted biopsy [VAB] devices, fine needle aspiration biopsy [FNAB] devices, core needle biopsy [CNB] devices, biopsy guidance systems, biopsy needles, biopsy forceps and others). Applications include trends and market estimates of key application areas (breast cancer, gastrointestinal cancer, lung cancer, liver cancer, prostate cancer and cervical cancer, among others). This report focuses on key imaging technologies used in the process of performing biopsies (ultrasound, magnetic resonance imaging [MRI], computed tomography [CT] and others). The report also reviews the supply chain from manufacturers to surgeons.

The report excludes drugs used during a biopsy and any device that is used in the cancer treatment process.

Report Includes:

  • 44 data tables and 21 additional tables
  • Detailed overview and an up-to-date analysis of the global market for biopsy devices
  • Analyses of the global market trends, with revenue data (sales figures) for 2021 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2027
  • Estimation of the actual market size and revenue forecast for the global biopsy devices market, and corresponding market share analysis by device type, therapeutic area/application, image guiding technology, end user, and region
  • Identification of the viable technology drivers and barriers through a holistic review of various next generation imaging technologies used in the process of performing biopsies and their key therapeutic areas in the cancer diagnostics market
  • Review of cancer statistics and epidemiology insights and SWOT analysis of various cancer biotherapeutics present in the market
  • A look at major issues and trends with relate to the R&D of more effective cancer treatment, and new cancer therapeutics in development, and outlook on cancer clinical trials
  • Assessment of the market growth opportunities, SWOT analysis of the leading companies engaged in manufacturing and development of biopsy devices, emerging trends and technology developments, along with the COVID-19 implications on the marketplace
  • Insight into the recent industry structure, competitive aspects of each product segments, increasing investment on R&D activities, market growth strategies, and company revenue share analysis
  • Patent grants and patent applications on biopsy devices and cancer diagnostics industry
  • Descriptive company profiles of the leading market players, including Argon Medical Devices Inc., Boston Scientific Corp., FujiFilm Holdings Corp., Mammotome, and Olympus Corp.

Table of Contents

Chapter 1 Introduction

  • 1.1 Study Goals and Objectives
  • 1.2 Reasons for Doing This Study
  • 1.3 Scope of Report
  • 1.4 What's New in This Update?
  • 1.5 Methodology and Information Sources
    • 1.5.1 Primary Data and Information Gathering
    • 1.5.2 Secondary Data and Information Gathering
    • 1.5.3 Market Share Analysis and Market Forecast Prediction
  • 1.6 Geographic Breakdown
  • 1.7 Analyst's Credentials
  • 1.8 BCC Custom Research
  • 1.9 Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Overview of Biopsy Devices

  • 3.1 Biopsy
  • 3.2 Types of Biopsies
    • 3.2.1 Bone Marrow Aspiration and Biopsy
    • 3.2.2 Core Biopsy
    • 3.2.3 Endometrial Biopsy
    • 3.2.4 Endoscopic Biopsy
    • 3.2.5 Excisional Biopsy and Incisional Biopsy
    • 3.2.6 Fine-Needle Aspiration (FNA) Biopsy
    • 3.2.7 Sentinel Lymph Node Biopsy
    • 3.2.8 Skin Biopsy
    • 3.2.9 Shave Biopsy
    • 3.2.10 Punch Biopsy
  • 3.3 Biopsy Devices
  • 3.4 Regulation of Biopsy Devices
    • 3.4.1 U.S. Regulation of Biopsy Devices
    • 3.4.2 EU Regulation of Biopsy Devices
    • 3.4.3 Reimbursement Policies
  • 3.5 Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Cancer Diagnostics and Imaging

Chapter 4 Biopsy Device Market by Product Type

  • 4.1 Introduction
  • 4.2 Biopsy Guidance Systems
  • 4.3 Needle-Based Biopsy Guns
    • 4.3.1 Core Needle Biopsy (CNB)
    • 4.3.2 Fine Needle Aspiration Biopsy (FNAB)
    • 4.3.3 Vacuum-Assisted Biopsy (VAB)
  • 4.4 Biopsy Needles
  • 4.5 Biopsy Forceps
  • 4.6 Others
    • 4.6.1 Biopsy Brushes
    • 4.6.2 Biopsy Curettes
    • 4.6.3 Biopsy Punches

Chapter 5 Biopsy Device Market by Imaging Guiding Technology

  • 5.1 Imaging Technologies Used in Guiding Biopsies
    • 5.1.1 MRI-Guided Biopsy
    • 5.1.2 Stereotactic-Guided Biopsy
    • 5.1.3 Advantages of Stereotactic-Guided Needle Biopsy
    • 5.1.4 Disadvantages of Stereotactic-Guided Needle Biopsy
    • 5.1.5 Ultrasound-Guided Biopsy
    • 5.1.6 Liver Biopsy
    • 5.1.7 Thyroid Biopsy
    • 5.1.8 Prostate Biopsy
    • 5.1.9 Breast Biopsy
    • 5.1.10 Trends
    • 5.1.11 Computed Tomography
    • 5.1.12 Advantages of CT-Guided Needle Biopsy
    • 5.1.13 Disadvantages of CT-Guided Needle Biopsy
    • 5.1.14 Limitations of CT-Guided Needle Biopsy
    • 5.1.15 Others

Chapter 6 Biopsy Device Market by Application

  • 6.1 Breast Biopsy
  • 6.2 GI Biopsy
  • 6.3 Prostate Biopsy
    • 6.3.1 Image-Guided Prostate Biopsy
    • 6.3.2 Risks of Biopsy of the Prostate
  • 6.4 Liver Biopsy
    • 6.4.1 Liver Biopsy Trends
    • 6.4.2 Liver Disease Facts
    • 6.4.3 Percutaneous Liver Biopsy
    • 6.4.4 Laproscopic Surgery
  • 6.5 Lung Biopsy
    • 6.5.1 Advantages of Lung Biopsy
    • 6.5.2 Disadvantages of Lung Biopsy
  • 6.6 Kidney Biopsy
    • 6.6.1 Complications of Biopsies to Detect Kidney Disease
    • 6.6.2 Advantages of Renal/Kidney Biopsy
    • 6.6.3 Disadvantages of Renal/Kidney Biopsy
  • 6.7 Gynecological Biopsy
    • 6.7.1 Complications of Gynecological Biopsy
  • 6.8 Biopsy Devices Used to Diagnose Other Diseases
    • 6.8.1 Pancreatic Cancer Biopsy
    • 6.8.2 Biopsies for Pancreatic Cancer

Chapter 7 Biopsy Device Market by End User

  • 7.1 Diagnostic Labs
  • 7.2 Hospitals

Chapter 8 Biopsy Device Market by Region

  • 8.1 Market Overview and Discussion
  • 8.2 North America
    • 8.2.1 Countries
  • 8.3 Europe
    • 8.3.1 Countries
  • 8.4 Asia-Pacific
    • 8.4.1 Countries
  • 8.5 RoW

Chapter 9 COVID-19 Impact

  • 9.1 Overview
  • 9.2 Impact of COVID-19 on Biopsy Devices

Chapter 10 Emerging Technologies in the Biopsy Device Market

  • 10.1 Cambridge Prostate Biopsy Device (CamPROBE)
  • 10.2 Microbiopsy Technology
  • 10.3 Virtual Biopsy Device
  • 10.4 Optical Biopsy

Chapter 11 Patent Review

  • 11.1 Introduction

Chapter 12 Competitive Landscape

  • 12.1 Global Company Ranking
    • 12.1.1 Other Key Players
    • 12.1.2 Recent News

Chapter 13 Company Profiles

  • ARGON MEDICAL DEVICES INC.
  • B. BRAUN MELSUNGEN AG
  • BECTON, DICKINSON AND CO. (CAREFUSION CORP.)
  • BOSTON SCIENTIFIC CORP.
  • CARDINAL HEALTH INC.
  • CONMED CORP.
  • COOK MEDICAL INC.
  • DTR MEDICAL LTD.
  • DANAHER CORP. (MAMMOTOME)
  • FUJIFILM HOLDINGS CORP.
  • HOLOGIC INC.
  • INRAD INC.
  • MERIT MEDICAL SYSTEMS INC.
  • MDNA LIFE SCIENCES INC.
  • MAUNA KEA TECHNOLOGIES
  • MEDTRONIC
  • MDXHEALTH INC.
  • OLYMPUS CORP.

Chapter 14 Appendix A: Company Addresses and Contact Details

  • 14.1 Company Address and Contact Details

Chapter 15 Appendix B: Abbreviations

List of Tables

  • Summary Table : Global Market for Biopsy Devices, by Region, Through 2027
  • Table 1 : Implementation of Breast Cancer Screening Programs, by Country
  • Table 2 : Cancer Deaths, 2020
  • Table 3 : No. People 65+, by Region, 2019 and 2050
  • Table 4 : Global Market for Biopsy Devices, by Product Type, Through 2027
  • Table 5 : Global Market for Biopsy Guidance Systems, by Region, Through 2027
  • Table 6 : Global Market for Needle-Based Biopsy Guns, by Region, Through 2027
  • Table 7 : Global Market for Needle-Based Biopsy Guns, by Product Type, Through 2027
  • Table 8 : Global Market for Core Needle Biopsy (CNB), by Region, Through 2027
  • Table 9 : Global Market for Fine Needle Aspiration Biopsy (FNAB), by Region, Through 2027
  • Table 10 : Global Market for Vacuum-Assisted Biopsy (VAB), by Region, Through 2027
  • Table 11 : Global Market for Biopsy Needles, by Region, Through 2027
  • Table 12 : Global Market for Biopsy Forceps, by Region, Through 2027
  • Table 13 : Global Market for Other Biopsy Devices, by Region, Through 2027
  • Table 14 : Global Market for Biopsy Devices, by Imaging Guiding Technology Type, Through 2027
  • Table 15 : Global Market for MRI-Guided Biopsy Devices, by Region, Through 2027
  • Table 16 : Global Market for Stereotactic Guided Biopsy Devices, by Region, Through 2027
  • Table 17 : Global Market for Ultrasound Guided Biopsy Devices, by Region, Through 2027
  • Table 18 : Global Market for CT-Guided Biopsy Devices, by Region, Through 2027
  • Table 19 : Global Market for Other Biopsy Imaging Devices, by Region, Through 2027
  • Table 20 : Global Market for Biopsy Devices, by Application, Through 2027
  • Table 21 : Global Market for Breast Biopsy Devices, by Region, Through 2027
  • Table 22 : Global Market for GI Biopsy Devices, by Region, Through 2027
  • Table 23 : Global Market for Prostate Biopsy Devices, by Region, Through 2027
  • Table 24 : Global Market for Liver Biopsy Devices, by Region, Through 2027
  • Table 25 : Global Market for Lung Biopsy Devices, by Region, Through 2027
  • Table 26 : Global Market for Kidney Biopsy Devices, by Region, Through 2027
  • Table 27 : Global Market for Gynecological Biopsy Devices, by Region, Through 2027
  • Table 28 : Global Market for Other Application of Biopsy Devices, by Region, Through 2027
  • Table 29 : Global Market for Biopsy Devices, by End User, Through 2027
  • Table 30 : Global Market for Biopsy Devices in Diagnostic Labs, by Region, Through 2027
  • Table 31 : Global Market for Biopsy Devices Used in Hospitals, by Region, Through 2027
  • Table 32 : Global Market for Biopsy Devices, by Region, Through 2027
  • Table 33 : North American Market for Biopsy Devices, by Country, Through 2027
  • Table 34 : European Market for Biopsy Devices, by Country, Through 2027
  • Table 35 : Asia-Pacific Market for Biopsy Devices, by Country, Through 2027
  • Table 36 : RoW Market for Biopsy Devices, Through 2027
  • Table 37 : U.S. Biopsy Device Patents, by Company, 2022-2023
  • Table 38 : European Biopsy Device Patents, by Company, 2022
  • Table 39 : Japanese Biopsy Device Patents, by Company, 2021-2022
  • Table 40 : Chinese Biopsy Device Patents, by Company, 2022
  • Table 41 : Japanese Biopsy Device Patents, by Company, 2021-2022
  • Table 42 : Global Market Rankings for Biopsy Devices, by Manufacturer, 2021
  • Table 43 : Argon Medical Devices Inc.: Product Portfolio
  • Table 44 : B. Braun Melsungen AG: Products
  • Table 45 : Becton, Dickinson and Co.: Financials, 2021
  • Table 46 : Boston Scientific Corp.: Product Portfolio
  • Table 47 : Boston Scientific Corp.: Recent Financial Performance, 2019-2021
  • Table 48 : Cardinal Health Inc.: Product Portfolio
  • Table 49 : Cardinal Health Inc.: Recent Financial Performance, 2019-2021
  • Table 50 : Conmed Corp.: Product Portfolio
  • Table 51 : Conmed Corp.: Recent Financial Performance, 2019-2021
  • Table 52 : Cook Medical Inc.: Product Portfolio
  • Table 53 : Mammotome: Product Portfolio
  • Table 54 : FujiFilm Holdings Corp.: Recent Financials, 2019-2021
  • Table 55 : Hologic Inc.: Product Portfolio
  • Table 56 : Hologic Inc.: Financials, 2021
  • Table 57 : INRAD Inc.: Product Portfolio
  • Table 58 : Merit Medical Systems: Product Portfolio
  • Table 59 : Merit Medical Systems: Recent Financials, 2019-2021
  • Table 60 : Medtronic: Product Portfolio
  • Table 61 : Medtronic: Financials, 2019-2022
  • Table 62 : Olympus Corp.: Recent Financials, 2019-2021
  • Table 63 : Company Address and Contact Details
  • Table 64 : Abbreviations

List of Figures

  • Summary Figure A : Global Market for Biopsy Devices, by Region, 2019-2027
  • Summary Figure B : Global Market Shares for Biopsy Devices, by Region, 2021
  • Figure 1 : Global Market for Biopsy Devices, by Product Type, 2019-2027
  • Figure 2 : Global Market Shares for Biopsy Devices, by Product Type, 2021
  • Figure 3 : Global Market for Biopsy Guidance Systems, by Region, 2019-2027
  • Figure 4 : Global Market Shares for Biopsy Guidance Systems, by Region, 2021
  • Figure 5 : Global Market for Needle-Based Biopsy Guns, by Product Type, 2019-2027
  • Figure 6 : Global Market Shares for Needle-Based Biopsy Guns, by Region, 2021
  • Figure 7 : Global Market for Needle-Based Biopsy Guns, by Product Type, 2019-2027
  • Figure 8 : Global Market Shares for Needle-Based Biopsy Guns, by Product Type, 2021
  • Figure 9 : Global Market for Biopsy Needles, by Region, 2019-2027
  • Figure 10 : Global Market Shares for Biopsy Needles, by Region, 2021
  • Figure 11 : Global Market for Biopsy Forceps, by Region, 2019-2027
  • Figure 12 : Global Market Shares for Biopsy Forceps, by Region, 2021
  • Figure 13 : Global Market for Other Biopsy Devices, by Region, 2019-2027
  • Figure 14 : Global Market Shares for Other Biopsy Devices, by Region, 2021
  • Figure 15 : Global Market for Biopsy Devices, by Imaging Guiding Technology Type, 2019-2027
  • Figure 16 : Global Market Shares for Biopsy Devices, by Imaging Guiding Technology Type, 2021
  • Figure 17 : Global Market for Biopsy Devices, by Application, 2019-2027
  • Figure 18 : Global Market Shares for Biopsy Devices, by Application, 2021Global Market Shares for Biopsy Devices, by Application, 2021
  • Figure 19 : Global Market for Biopsy Devices, by End User, 2019-2027
  • Figure 20 : Global Market Shares for Biopsy Devices, by End User, 2021
  • Figure 21 : Global Market for Biopsy Devices, by Region, 2019-2027
  • Figure 22 : Global Market Shares for Biopsy Devices, by Region, 2021
  • Figure 23 : North American Market Shares for Biopsy Devices, by Country, 2021
  • Figure 24 : European Market Shares for Biopsy Devices, by Country, 2021
  • Figure 25 : Asia-Pacific Market Shares for Biopsy Devices, by Country, 2021
  • Figure 26 : B. Braun Melsungen AG: Revenue, 2019-2021
  • Figure 27 : B. Braun Melsungen AG: Revenue Share, by Country/Region, 2021
  • Figure 28 : B. Braun Melsungen AG: Revenue Share, by Segment, 2021
  • Figure 29 : Becton, Dickinson and Co.: Revenue Share, by Business Unit, 2021
  • Figure 30 : Becton, Dickinson and Co.: Revenue Share, by Country/Region, 2021
  • Figure 31 : Boston Scientific Corp.: Revenue Share, by Product Segment, 2021
  • Figure 32 : Cardinal Health Inc.: Revenue Share, by Segment, 2021
  • Figure 33 : Conmed Corp.: Revenue Share, by Segment, 2021
  • Figure 34 : FujiFilm Holdings Corp.: Revenue Share, by Segment, 2021
  • Figure 35 : FujiFilm Holdings Corp.: Revenue Share, by Country/Region, 2021
  • Figure 36 : Hologic Inc.: Financials, 2019-2022
  • Figure 37 : Hologic Inc.: Revenue Share, by Country/Region, 2021
  • Figure 38 : Hologic Inc.: Revenue Share, by Segment, 2021
  • Figure 39 : Merit Medical Systems: Revenue Share, by Business Segment, 2021
  • Figure 40 : Medtronic: Revenue Share, by Key Disease Segment, 2022
  • Figure 41 : Olympus Corp.: Revenue Share, by Business Segment, 2021